Literature DB >> 14593696

Cell cycle deregulation: a common motif in cancer.

Marcos Malumbres1, Amancio Carnero.   

Abstract

Uncontrolled proliferation is a hallmark of cancer cells. Molecular analysis of human tumors and animal models have provided a clear basis for the understanding of the cellular processes that govern cell cycle progression in normal and tumor cells. Many cell cycle regulators controlling the correct entry and progression through the cell cycle are altered in tumors. In fact, most, if not all, human cancers show a deregulated control of G1 progression, a period when cells decide whether to start proliferation or to stay quiescent. In addition, tumor cells have impaired cell cycle checkpoints, resulting in the accumulation of genetic aberrations. Manipulation of these control mechanisms provides new avenues for the design of advanced therapeutic strategies against tumor development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593696

Source DB:  PubMed          Journal:  Prog Cell Cycle Res        ISSN: 1087-2957


  39 in total

Review 1.  Bypassing cellular senescence by genetic screening tools.

Authors:  Mar Vergel; Amancio Carnero
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

2.  Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis.

Authors:  Pierre Lao-Sirieix; Rebecca Brais; Laurence Lovat; Nicholas Coleman; Rebecca C Fitzgerald
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

Review 3.  Therapeutic opportunities to control tumor cell cycles.

Authors:  Marcos Malumbres
Journal:  Clin Transl Oncol       Date:  2006-06       Impact factor: 3.405

4.  Battling cancer on many fronts. Meeting on New Battlefields in Human Cancer--Attacking in Many Fronts.

Authors:  Fabian Zanella; Amancio Carnero
Journal:  EMBO Rep       Date:  2008-09       Impact factor: 8.807

5.  Long non-coding RNA SNHG1 promotes Cyclin D1-mediated proliferation in pancreatic cancer by acting as a ceRNA of miR-195.

Authors:  Dong Li; Xuming Zhang; Yuxi Yang; Yi Shen; Qibing Zhang; Hong Liu; Xiaofeng Li; Chunqiu Zhang; Pengyu Liu; Xiangzheng Qin
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

6.  Early G₁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma.

Authors:  Amin Ismail; Santhoshi Bandla; Marie Reveiller; Liana Toia; Zhongren Zhou; William E Gooding; Irina Kalatskaya; Lincoln Stein; Mary D'Souza; Virginia R Litle; Jeffrey H Peters; Arjun Pennathur; James D Luketich; Tony E Godfrey
Journal:  Clin Cancer Res       Date:  2011-05-18       Impact factor: 12.531

7.  Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.

Authors:  M Montopoli; E Ragazzi; G Froldi; L Caparrotta
Journal:  Cell Prolif       Date:  2009-02-18       Impact factor: 6.831

8.  Upregulation of SYF2 in esophageal squamous cell carcinoma promotes tumor cell proliferation and predicts poor prognosis.

Authors:  Junya Zhu; Lili Ji; Jianguo Zhang; Lei Yang; Chengqi Guan; Yayun Wang; Jia Zhu; Li Liang; Runzhou Ni
Journal:  Tumour Biol       Date:  2014-07-18

9.  Lifestyle chemical carcinogens associated with mutations in cell cycle regulatory genes increases the susceptibility to gastric cancer risk.

Authors:  Ravi Prakash Yadav; Souvik Ghatak; Payel Chakraborty; Freda Lalrohlui; Ravi Kannan; Rajeev Kumar; Jeremy L Pautu; John Zomingthanga; Saia Chenkual; Rajendra Muthukumaran; Nachimuthu Senthil Kumar
Journal:  Environ Sci Pollut Res Int       Date:  2018-09-12       Impact factor: 4.223

Review 10.  Disruptive chemicals, senescence and immortality.

Authors:  Amancio Carnero; Carmen Blanco-Aparicio; Hiroshi Kondoh; Matilde E Lleonart; Juan Fernando Martinez-Leal; Chiara Mondello; A Ivana Scovassi; William H Bisson; Amedeo Amedei; Rabindra Roy; Jordan Woodrick; Annamaria Colacci; Monica Vaccari; Jayadev Raju; Fahd Al-Mulla; Rabeah Al-Temaimi; Hosni K Salem; Lorenzo Memeo; Stefano Forte; Neetu Singh; Roslida A Hamid; Elizabeth P Ryan; Dustin G Brown; John Pierce Wise; Sandra S Wise; Hemad Yasaei
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.